SPY328.73+5.23 1.62%
DIA271.70+3.60 1.34%
IXIC10,913.56+241.30 2.26%

Raymond James Initiates Coverage On Global Blood Therapeutics with Outperform Rating, Announces Price Target of $115

Raymond James analyst Danielle Brill initiates coverage on Global Blood Therapeutics (NASDAQ:GBT) with a Outperform rating and announces Price Target of $115.

Benzinga · 08/25/2020 10:50
Raymond James analyst Danielle Brill initiates coverage on Global Blood Therapeutics (NASDAQ: GBT) with a Outperform rating and announces Price Target of $115.